摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-甲氧基-2,2-二甲基-1-丙胺盐酸盐(1:1) | 171268-71-6

中文名称
3-甲氧基-2,2-二甲基-1-丙胺盐酸盐(1:1)
中文别名
(2R,3S,5S)-3-(苄氧基)-5-[2-[[(4-甲氧苯基)二苯甲基]氨基]-6-(苄氧基)-9H-嘌呤-9-基]-2-(苄氧基甲基)环戊酮;3-甲氧基-2,2-二甲基丙烷-1-胺盐酸
英文名称
3-methoxy-2,2-dimethylpropan-1-amine hydrochloride
英文别名
(3-Methoxy-2,2-dimethylpropyl)amine hydrochloride;3-methoxy-2,2-dimethylpropan-1-amine;hydrochloride
3-甲氧基-2,2-二甲基-1-丙胺盐酸盐(1:1)化学式
CAS
171268-71-6
化学式
C6H15NO*ClH
mdl
MFCD12031492
分子量
153.652
InChiKey
IXJYFALFWJVGKE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    100-102°C
  • 溶解度:
    可溶于氯仿、甲醇

计算性质

  • 辛醇/水分配系数(LogP):
    0.36
  • 重原子数:
    9
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    35.2
  • 氢给体数:
    2
  • 氢受体数:
    2

SDS

SDS:84ea4e322d1d9f612e58240e3f157c1f
查看

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] SULFONE AMIDE LINKED BENZOTHIAZOLE INHIBITORS OF ENDOTHELIAL LIPASE<br/>[FR] COMPOSÉS BENZOTHIAZOLE À LIAISON AMIDE SULFONE UTILISÉS EN TANT QU'INHIBITEURS DE LA LIPASE ENDOTHÉLIALE
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2015105749A1
    公开(公告)日:2015-07-16
    The present invention provides compounds of Formula (I) as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used medicaments.
    本发明提供了规范中定义的Formula (I)的化合物以及包含任何此类新化合物的组合物。这些化合物是内皮脂酶抑制剂,可用作药物。
  • NITROGEN CONTAINING HETEROARYL COMPOUNDS
    申请人:Bleicher Konrad
    公开号:US20110306589A1
    公开(公告)日:2011-12-15
    The invention is concerned with novel nitrogen-containing heteroaryl compounds of formula (I) wherein A 1 , A 2 , R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used as therapeutics.
    这项发明涉及一种新颖的含氮杂环芳基化合物,其化学式为(I),其中A1、A2、R1、R2、R3、R4、R5和R6如描述和索赔中所定义,并且其生理上可接受的盐和酯。这些化合物抑制PDE10A并可用作治疗药物。
  • AMIDE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL
    申请人:SUMITOMO CHEMICAL COMPANY, LIMITED
    公开号:US20170295789A1
    公开(公告)日:2017-10-19
    There is provided a noxious arthropod controlling agent containing an amide compound of formula (I): wherein R 1 represents a C1-C8 chain hydrocarbon group optionally having one or more groups selected from Group A, R 2 represents a hydrogen atom or the like, R 3 represents a hydrogen atom or the like, R 5 and R 6 are the same or different, and independently represent a hydrogen atom or the like, Y represents an oxygen atom or the like, m represents 0, 1, 2, 3, 4, 5, 6 or 7, and Q represents a C1-C8 chain hydrocarbon group optionally having one or more atoms or groups selected from Group D.
    提供了一种含有化合物的有害节肢动物控制剂(I)的公式:其中R1代表一个C1-C8链烃基,可选地具有来自A组的一个或多个基团,R2代表氢原子或类似物,R3代表氢原子或类似物,R5和R6相同或不同,独立地代表氢原子或类似物,Y代表氧原子或类似物,m代表0、1、2、3、4、5、6或7,Q代表一个C1-C8链烃基,可选地具有来自D组的一个或多个原子或基团。
  • Novel imidazo based heterocycles
    申请人:Calderwood J. David
    公开号:US20070099925A1
    公开(公告)日:2007-05-03
    The present invention is directed to novel imidazopyrazine and imidazopyrimidine compounds of formula (I) wherein the variables are as defined herein. The compounds of formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, cancers.
    本发明涉及式(I)的新型咪唑吡嗪和咪唑嘧啶化合物,其中变量如在此定义。式(I)的化合物可用作激酶抑制剂,因此可用于治疗某些疾病和病症,特别是炎症性疾病和增殖性疾病和病症,例如癌症。
  • Nitrogen containing heteroaryl compounds
    申请人:Bleicher Konrad
    公开号:US08703768B2
    公开(公告)日:2014-04-22
    The invention is concerned with novel nitrogen-containing heteroaryl compounds of formula (I) wherein A1, A2, R1, R2, R3, R4, R5 and R6 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used as therapeutics.
    本发明涉及一种新型的含氮杂环芳基化合物,其化学式为(I),其中A1、A2、R1、R2、R3、R4、R5和R6如描述和权利要求中所定义,以及其生理学上可接受的盐和酯。这些化合物抑制PDE10A并可用作治疗药物。
查看更多